Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3650-3654
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3650
Advances in minimally invasive treatment of malignant obstructive jaundice
Li-Min Kang, Lei Xu, Fa-Kun Yu, Fu-Wei Zhang, Li Lang
Li-Min Kang, Lei Xu, Fa-Kun Yu, Fu-Wei Zhang, Department of Hepatobiliary and Pancreatic Surgery, Puer People’s Hospital, Puer 665000, Yunnan Province, China
Li Lang, Department of Outpatient, Puer People’s Hospital, Puer 665000, Yunnan Province, China
Author contributions: Kang LM, Xu L, Yu FK, Zhang FW, Lang L designed the overall concept and outline of the manuscript; Kang LM, Xu L, Lang L contributed to writing and editing the manuscript and review of literature; All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Li-Min Kang, PhD, Doctor, Surgeon, Department of Hepatobiliary and Pancreatic Surgery, Puer People’s Hospital, No. 44 Zhenxing Street, Puer 665000, Yunnan Province, China. kanglimin2010@163.com
Received: May 19, 2024
Revised: August 22, 2024
Accepted: September 6, 2024
Published online: December 27, 2024
Processing time: 192 Days and 3.7 Hours
Core Tip

Core Tip: Malignant obstructive jaundice (MOJ) presents with a subtle onset and poses challenges in early detection. By the time jaundice becomes apparent, the disease has typically advanced to a stage where surgical intervention is no longer feasible. Minimally invasive procedures for jaundice reduction are often the only viable option for the patients, as radical surgery is not feasible. In clinical practice, attention should be paid to the factors such as the underlying cause of MOJ, the degree of bile duct obstruction, the severity of jaundice, the patient’s overall health status and expected prognosis, and the surgical expertise available at the respective medical facility.